nodes	percent_of_prediction	percent_of_DWPC	metapath
Progesterone—uterine cancer—muscle cancer	0.608	1	CtDrD
Progesterone—ABCC1—Dactinomycin—muscle cancer	0.034	0.108	CbGbCtD
Progesterone—SLC22A3—Vincristine—muscle cancer	0.032	0.102	CbGbCtD
Progesterone—ABCB11—Vincristine—muscle cancer	0.0294	0.0933	CbGbCtD
Progesterone—CYP1A1—Dacarbazine—muscle cancer	0.0242	0.0767	CbGbCtD
Progesterone—ABCC1—Vincristine—muscle cancer	0.0209	0.0663	CbGbCtD
Progesterone—ABCC1—Etoposide—muscle cancer	0.0192	0.0607	CbGbCtD
Progesterone—CYP1B1—Doxorubicin—muscle cancer	0.0184	0.0583	CbGbCtD
Progesterone—ABCB11—Doxorubicin—muscle cancer	0.0184	0.0583	CbGbCtD
Progesterone—ABCC1—Doxorubicin—muscle cancer	0.0131	0.0414	CbGbCtD
Progesterone—ABCC1—Methotrexate—muscle cancer	0.0127	0.0401	CbGbCtD
Progesterone—CYP1A2—Dacarbazine—muscle cancer	0.0108	0.0343	CbGbCtD
Progesterone—CYP3A7—Vincristine—muscle cancer	0.0103	0.0328	CbGbCtD
Progesterone—CYP3A7-CYP3A51P—Vincristine—muscle cancer	0.0103	0.0328	CbGbCtD
Progesterone—ABCB1—Dactinomycin—muscle cancer	0.00819	0.026	CbGbCtD
Progesterone—CYP3A5—Vincristine—muscle cancer	0.00775	0.0246	CbGbCtD
Progesterone—CYP3A5—Etoposide—muscle cancer	0.0071	0.0225	CbGbCtD
Progesterone—CYP2C8—Etoposide—muscle cancer	0.00683	0.0217	CbGbCtD
Progesterone—CYP1A2—Etoposide—muscle cancer	0.00529	0.0168	CbGbCtD
Progesterone—ABCB1—Vincristine—muscle cancer	0.00505	0.016	CbGbCtD
Progesterone—ABCB1—Etoposide—muscle cancer	0.00462	0.0147	CbGbCtD
Progesterone—AR—scrotum—muscle cancer	0.00352	0.138	CbGeAlD
Progesterone—ABCB1—Doxorubicin—muscle cancer	0.00315	0.01	CbGbCtD
Progesterone—ABCB1—Methotrexate—muscle cancer	0.00305	0.00968	CbGbCtD
Progesterone—CYP3A4—Vincristine—muscle cancer	0.00302	0.00958	CbGbCtD
Progesterone—CYP2D6—Doxorubicin—muscle cancer	0.00297	0.00942	CbGbCtD
Progesterone—CYP3A4—Etoposide—muscle cancer	0.00277	0.00878	CbGbCtD
Progesterone—CYP3A4—Doxorubicin—muscle cancer	0.00189	0.00599	CbGbCtD
Progesterone—SHBG—hindlimb—muscle cancer	0.00167	0.0655	CbGeAlD
Progesterone—SLC10A1—renal system—muscle cancer	0.000555	0.0218	CbGeAlD
Progesterone—CYP17A1—renal system—muscle cancer	0.000484	0.0189	CbGeAlD
Progesterone—SLC22A2—renal system—muscle cancer	0.00044	0.0173	CbGeAlD
Progesterone—SLC22A3—embryo—muscle cancer	0.000393	0.0154	CbGeAlD
Progesterone—SLC10A1—head—muscle cancer	0.000371	0.0146	CbGeAlD
Progesterone—NR3C2—smooth muscle tissue—muscle cancer	0.000363	0.0142	CbGeAlD
Progesterone—SLC10A1—testis—muscle cancer	0.000359	0.0141	CbGeAlD
Progesterone—ABCB11—testis—muscle cancer	0.000355	0.0139	CbGeAlD
Progesterone—NR3C2—renal system—muscle cancer	0.000349	0.0137	CbGeAlD
Progesterone—PGR—smooth muscle tissue—muscle cancer	0.000337	0.0132	CbGeAlD
Progesterone—ESR1—embryo—muscle cancer	0.000336	0.0132	CbGeAlD
Progesterone—OPRK1—head—muscle cancer	0.000327	0.0128	CbGeAlD
Progesterone—CYP17A1—head—muscle cancer	0.000324	0.0127	CbGeAlD
Progesterone—NR3C2—cardiac atrium—muscle cancer	0.000313	0.0123	CbGeAlD
Progesterone—CYP17A1—testis—muscle cancer	0.000313	0.0122	CbGeAlD
Progesterone—SLC22A1—renal system—muscle cancer	0.000311	0.0122	CbGeAlD
Progesterone—SLC22A3—smooth muscle tissue—muscle cancer	0.000309	0.0121	CbGeAlD
Progesterone—SIGMAR1—smooth muscle tissue—muscle cancer	0.000298	0.0117	CbGeAlD
Progesterone—SLC22A3—renal system—muscle cancer	0.000297	0.0116	CbGeAlD
Progesterone—CYP1B1—smooth muscle tissue—muscle cancer	0.000284	0.0111	CbGeAlD
Progesterone—CYP1B1—renal system—muscle cancer	0.000273	0.0107	CbGeAlD
Progesterone—NR3C2—tendon—muscle cancer	0.000273	0.0107	CbGeAlD
Progesterone—SHBG—bone marrow—muscle cancer	0.000273	0.0107	CbGeAlD
Progesterone—CYP2A6—vagina—muscle cancer	0.00027	0.0106	CbGeAlD
Progesterone—AR—smooth muscle tissue—muscle cancer	0.000269	0.0105	CbGeAlD
Progesterone—ESR1—smooth muscle tissue—muscle cancer	0.000264	0.0103	CbGeAlD
Progesterone—SHBG—vagina—muscle cancer	0.000261	0.0102	CbGeAlD
Progesterone—AR—renal system—muscle cancer	0.000259	0.0101	CbGeAlD
Progesterone—SIGMAR1—cardiac atrium—muscle cancer	0.000257	0.0101	CbGeAlD
Progesterone—ESR1—renal system—muscle cancer	0.000254	0.00995	CbGeAlD
Progesterone—NR3C2—vagina—muscle cancer	0.000253	0.00992	CbGeAlD
Progesterone—NR3C1—embryo—muscle cancer	0.000248	0.0097	CbGeAlD
Progesterone—PGR—vagina—muscle cancer	0.000235	0.00922	CbGeAlD
Progesterone—NR3C2—head—muscle cancer	0.000234	0.00916	CbGeAlD
Progesterone—SHBG—testis—muscle cancer	0.000233	0.00913	CbGeAlD
Progesterone—AR—cardiac atrium—muscle cancer	0.000232	0.00908	CbGeAlD
Progesterone—NR3C2—testis—muscle cancer	0.000226	0.00885	CbGeAlD
Progesterone—SLC22A1—vagina—muscle cancer	0.000225	0.00883	CbGeAlD
Progesterone—SIGMAR1—tendon—muscle cancer	0.000224	0.00879	CbGeAlD
Progesterone—ABCC1—cardiac atrium—muscle cancer	0.00022	0.00862	CbGeAlD
Progesterone—PGR—head—muscle cancer	0.000217	0.00851	CbGeAlD
Progesterone—SIGMAR1—bone marrow—muscle cancer	0.000217	0.00851	CbGeAlD
Progesterone—SLC22A3—vagina—muscle cancer	0.000215	0.00844	CbGeAlD
Progesterone—CYP1B1—tendon—muscle cancer	0.000213	0.00836	CbGeAlD
Progesterone—PGR—testis—muscle cancer	0.00021	0.00823	CbGeAlD
Progesterone—CYP2C8—renal system—muscle cancer	0.000209	0.0082	CbGeAlD
Progesterone—SIGMAR1—vagina—muscle cancer	0.000208	0.00816	CbGeAlD
Progesterone—SLC22A1—head—muscle cancer	0.000208	0.00815	CbGeAlD
Progesterone—AR—tendon—muscle cancer	0.000202	0.00791	CbGeAlD
Progesterone—SLC22A3—head—muscle cancer	0.000199	0.00779	CbGeAlD
Progesterone—CYP1A2—renal system—muscle cancer	0.000196	0.00767	CbGeAlD
Progesterone—NR3C1—smooth muscle tissue—muscle cancer	0.000195	0.00763	CbGeAlD
Progesterone—CYP1A1—renal system—muscle cancer	0.000193	0.00757	CbGeAlD
Progesterone—SLC22A3—testis—muscle cancer	0.000192	0.00753	CbGeAlD
Progesterone—ABCC1—tendon—muscle cancer	0.000192	0.00752	CbGeAlD
Progesterone—CYP3A5—renal system—muscle cancer	0.000189	0.0074	CbGeAlD
Progesterone—AR—vagina—muscle cancer	0.000187	0.00734	CbGeAlD
Progesterone—NR3C1—renal system—muscle cancer	0.000187	0.00734	CbGeAlD
Progesterone—SIGMAR1—testis—muscle cancer	0.000186	0.00728	CbGeAlD
Progesterone—ESR1—vagina—muscle cancer	0.000184	0.00721	CbGeAlD
Progesterone—CYP1B1—head—muscle cancer	0.000183	0.00716	CbGeAlD
Progesterone—ABCC1—vagina—muscle cancer	0.000178	0.00698	CbGeAlD
Progesterone—CYP1B1—testis—muscle cancer	0.000177	0.00692	CbGeAlD
Progesterone—CYP2C19—vagina—muscle cancer	0.000174	0.0068	CbGeAlD
Progesterone—AR—head—muscle cancer	0.000173	0.00678	CbGeAlD
Progesterone—CYP1A1—cardiac atrium—muscle cancer	0.000173	0.00678	CbGeAlD
Progesterone—ESR1—head—muscle cancer	0.00017	0.00666	CbGeAlD
Progesterone—NR3C1—cardiac atrium—muscle cancer	0.000168	0.00658	CbGeAlD
Progesterone—AR—testis—muscle cancer	0.000167	0.00655	CbGeAlD
Progesterone—ESR1—testis—muscle cancer	0.000164	0.00643	CbGeAlD
Progesterone—ABCC1—testis—muscle cancer	0.000159	0.00622	CbGeAlD
Progesterone—CYP2C8—vagina—muscle cancer	0.000152	0.00594	CbGeAlD
Progesterone—NR3C1—tendon—muscle cancer	0.000146	0.00573	CbGeAlD
Progesterone—CYP3A4—renal system—muscle cancer	0.000142	0.00555	CbGeAlD
Progesterone—NR3C1—bone marrow—muscle cancer	0.000142	0.00555	CbGeAlD
Progesterone—CYP1A1—vagina—muscle cancer	0.00014	0.00548	CbGeAlD
Progesterone—CYP2D6—renal system—muscle cancer	0.000139	0.00547	CbGeAlD
Progesterone—CYP3A5—vagina—muscle cancer	0.000137	0.00536	CbGeAlD
Progesterone—NR3C1—vagina—muscle cancer	0.000136	0.00532	CbGeAlD
Progesterone—CYP2C8—testis—muscle cancer	0.000135	0.0053	CbGeAlD
Progesterone—ABCB1—embryo—muscle cancer	0.000133	0.00519	CbGeAlD
Progesterone—CYP1A1—head—muscle cancer	0.000129	0.00506	CbGeAlD
Progesterone—NR3C1—head—muscle cancer	0.000125	0.00491	CbGeAlD
Progesterone—NR3C1—testis—muscle cancer	0.000121	0.00475	CbGeAlD
Progesterone—ABCB1—renal system—muscle cancer	0.0001	0.00393	CbGeAlD
Progesterone—CYP2D6—head—muscle cancer	9.33e-05	0.00366	CbGeAlD
Progesterone—CYP2D6—testis—muscle cancer	9.01e-05	0.00353	CbGeAlD
Progesterone—Decreased appetite—Vincristine—muscle cancer	8.95e-05	0.0018	CcSEcCtD
Progesterone—Cough—Etoposide—muscle cancer	8.91e-05	0.00179	CcSEcCtD
Progesterone—Gastrointestinal disorder—Vincristine—muscle cancer	8.89e-05	0.00178	CcSEcCtD
Progesterone—Fatigue—Vincristine—muscle cancer	8.87e-05	0.00178	CcSEcCtD
Progesterone—Convulsion—Etoposide—muscle cancer	8.85e-05	0.00178	CcSEcCtD
Progesterone—Hypertension—Etoposide—muscle cancer	8.82e-05	0.00177	CcSEcCtD
Progesterone—Pain—Vincristine—muscle cancer	8.8e-05	0.00177	CcSEcCtD
Progesterone—Constipation—Vincristine—muscle cancer	8.8e-05	0.00177	CcSEcCtD
Progesterone—Pain in extremity—Doxorubicin—muscle cancer	8.8e-05	0.00177	CcSEcCtD
Progesterone—Diplopia—Doxorubicin—muscle cancer	8.8e-05	0.00177	CcSEcCtD
Progesterone—Osteoarthritis—Doxorubicin—muscle cancer	8.8e-05	0.00177	CcSEcCtD
Progesterone—Asthma—Methotrexate—muscle cancer	8.78e-05	0.00176	CcSEcCtD
Progesterone—Chest pain—Etoposide—muscle cancer	8.7e-05	0.00175	CcSEcCtD
Progesterone—Affect lability—Doxorubicin—muscle cancer	8.66e-05	0.00174	CcSEcCtD
Progesterone—Migraine—Doxorubicin—muscle cancer	8.66e-05	0.00174	CcSEcCtD
Progesterone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	8.64e-05	0.00173	CcSEcCtD
Progesterone—Discomfort—Etoposide—muscle cancer	8.59e-05	0.00172	CcSEcCtD
Progesterone—Face oedema—Doxorubicin—muscle cancer	8.49e-05	0.0017	CcSEcCtD
Progesterone—Hypersensitivity—Dactinomycin—muscle cancer	8.49e-05	0.0017	CcSEcCtD
Progesterone—Abdominal discomfort—Methotrexate—muscle cancer	8.42e-05	0.00169	CcSEcCtD
Progesterone—Gastrointestinal pain—Vincristine—muscle cancer	8.42e-05	0.00169	CcSEcCtD
Progesterone—Confusional state—Etoposide—muscle cancer	8.41e-05	0.00169	CcSEcCtD
Progesterone—Anaphylactic shock—Etoposide—muscle cancer	8.34e-05	0.00167	CcSEcCtD
Progesterone—Mood swings—Doxorubicin—muscle cancer	8.34e-05	0.00167	CcSEcCtD
Progesterone—Infection—Etoposide—muscle cancer	8.28e-05	0.00166	CcSEcCtD
Progesterone—Asthenia—Dactinomycin—muscle cancer	8.27e-05	0.00166	CcSEcCtD
Progesterone—Dysuria—Methotrexate—muscle cancer	8.21e-05	0.00165	CcSEcCtD
Progesterone—Upper respiratory tract infection—Methotrexate—muscle cancer	8.16e-05	0.00164	CcSEcCtD
Progesterone—Tachycardia—Etoposide—muscle cancer	8.14e-05	0.00163	CcSEcCtD
Progesterone—Abdominal pain—Vincristine—muscle cancer	8.14e-05	0.00163	CcSEcCtD
Progesterone—Body temperature increased—Vincristine—muscle cancer	8.14e-05	0.00163	CcSEcCtD
Progesterone—Liver function test abnormal—Doxorubicin—muscle cancer	8.12e-05	0.00163	CcSEcCtD
Progesterone—Skin disorder—Etoposide—muscle cancer	8.1e-05	0.00163	CcSEcCtD
Progesterone—Hyperhidrosis—Etoposide—muscle cancer	8.06e-05	0.00162	CcSEcCtD
Progesterone—Breast disorder—Doxorubicin—muscle cancer	7.95e-05	0.0016	CcSEcCtD
Progesterone—Anorexia—Etoposide—muscle cancer	7.95e-05	0.00159	CcSEcCtD
Progesterone—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	7.92e-05	0.00159	CcSEcCtD
Progesterone—Diarrhoea—Dactinomycin—muscle cancer	7.88e-05	0.00158	CcSEcCtD
Progesterone—Pneumonia—Methotrexate—muscle cancer	7.88e-05	0.00158	CcSEcCtD
Progesterone—Nasopharyngitis—Doxorubicin—muscle cancer	7.87e-05	0.00158	CcSEcCtD
Progesterone—Infestation NOS—Methotrexate—muscle cancer	7.83e-05	0.00157	CcSEcCtD
Progesterone—Infestation—Methotrexate—muscle cancer	7.83e-05	0.00157	CcSEcCtD
Progesterone—Drowsiness—Methotrexate—muscle cancer	7.83e-05	0.00157	CcSEcCtD
Progesterone—Depression—Methotrexate—muscle cancer	7.81e-05	0.00157	CcSEcCtD
Progesterone—Hypotension—Etoposide—muscle cancer	7.79e-05	0.00156	CcSEcCtD
Progesterone—Gastritis—Doxorubicin—muscle cancer	7.79e-05	0.00156	CcSEcCtD
Progesterone—Alanine aminotransferase increased—Doxorubicin—muscle cancer	7.76e-05	0.00156	CcSEcCtD
Progesterone—Abdominal distension—Doxorubicin—muscle cancer	7.66e-05	0.00154	CcSEcCtD
Progesterone—Conjunctivitis—Methotrexate—muscle cancer	7.61e-05	0.00153	CcSEcCtD
Progesterone—Asthma—Doxorubicin—muscle cancer	7.6e-05	0.00153	CcSEcCtD
Progesterone—Dysphagia—Doxorubicin—muscle cancer	7.6e-05	0.00153	CcSEcCtD
Progesterone—ABCB1—bone marrow—muscle cancer	7.59e-05	0.00297	CbGeAlD
Progesterone—Hypersensitivity—Vincristine—muscle cancer	7.58e-05	0.00152	CcSEcCtD
Progesterone—Paraesthesia—Etoposide—muscle cancer	7.49e-05	0.0015	CcSEcCtD
Progesterone—Dyspnoea—Etoposide—muscle cancer	7.43e-05	0.00149	CcSEcCtD
Progesterone—Somnolence—Etoposide—muscle cancer	7.41e-05	0.00149	CcSEcCtD
Progesterone—Angina pectoris—Doxorubicin—muscle cancer	7.41e-05	0.00149	CcSEcCtD
Progesterone—Hepatobiliary disease—Methotrexate—muscle cancer	7.41e-05	0.00149	CcSEcCtD
Progesterone—Asthenia—Vincristine—muscle cancer	7.38e-05	0.00148	CcSEcCtD
Progesterone—Vomiting—Dactinomycin—muscle cancer	7.32e-05	0.00147	CcSEcCtD
Progesterone—Bronchitis—Doxorubicin—muscle cancer	7.31e-05	0.00147	CcSEcCtD
Progesterone—ABCB1—vagina—muscle cancer	7.27e-05	0.00285	CbGeAlD
Progesterone—Rash—Dactinomycin—muscle cancer	7.26e-05	0.00146	CcSEcCtD
Progesterone—Decreased appetite—Etoposide—muscle cancer	7.25e-05	0.00145	CcSEcCtD
Progesterone—Gastrointestinal disorder—Etoposide—muscle cancer	7.2e-05	0.00144	CcSEcCtD
Progesterone—Fatigue—Etoposide—muscle cancer	7.19e-05	0.00144	CcSEcCtD
Progesterone—Pain—Etoposide—muscle cancer	7.13e-05	0.00143	CcSEcCtD
Progesterone—Constipation—Etoposide—muscle cancer	7.13e-05	0.00143	CcSEcCtD
Progesterone—Dysuria—Doxorubicin—muscle cancer	7.11e-05	0.00143	CcSEcCtD
Progesterone—Upper respiratory tract infection—Doxorubicin—muscle cancer	7.07e-05	0.00142	CcSEcCtD
Progesterone—Haemoglobin—Methotrexate—muscle cancer	7.07e-05	0.00142	CcSEcCtD
Progesterone—Diarrhoea—Vincristine—muscle cancer	7.04e-05	0.00141	CcSEcCtD
Progesterone—Haemorrhage—Methotrexate—muscle cancer	7.03e-05	0.00141	CcSEcCtD
Progesterone—Hepatitis—Methotrexate—muscle cancer	7.03e-05	0.00141	CcSEcCtD
Progesterone—Pollakiuria—Doxorubicin—muscle cancer	7.02e-05	0.00141	CcSEcCtD
Progesterone—Pharyngitis—Methotrexate—muscle cancer	6.98e-05	0.0014	CcSEcCtD
Progesterone—Urinary tract disorder—Methotrexate—muscle cancer	6.94e-05	0.00139	CcSEcCtD
Progesterone—Weight increased—Doxorubicin—muscle cancer	6.92e-05	0.00139	CcSEcCtD
Progesterone—Urethral disorder—Methotrexate—muscle cancer	6.89e-05	0.00138	CcSEcCtD
Progesterone—Weight decreased—Doxorubicin—muscle cancer	6.88e-05	0.00138	CcSEcCtD
Progesterone—Feeling abnormal—Etoposide—muscle cancer	6.87e-05	0.00138	CcSEcCtD
Progesterone—Hyperglycaemia—Doxorubicin—muscle cancer	6.86e-05	0.00138	CcSEcCtD
Progesterone—Nausea—Dactinomycin—muscle cancer	6.84e-05	0.00137	CcSEcCtD
Progesterone—Pneumonia—Doxorubicin—muscle cancer	6.82e-05	0.00137	CcSEcCtD
Progesterone—Gastrointestinal pain—Etoposide—muscle cancer	6.82e-05	0.00137	CcSEcCtD
Progesterone—Dizziness—Vincristine—muscle cancer	6.81e-05	0.00137	CcSEcCtD
Progesterone—Infestation NOS—Doxorubicin—muscle cancer	6.78e-05	0.00136	CcSEcCtD
Progesterone—Infestation—Doxorubicin—muscle cancer	6.78e-05	0.00136	CcSEcCtD
Progesterone—Drowsiness—Doxorubicin—muscle cancer	6.78e-05	0.00136	CcSEcCtD
Progesterone—Visual impairment—Methotrexate—muscle cancer	6.77e-05	0.00136	CcSEcCtD
Progesterone—ABCB1—head—muscle cancer	6.71e-05	0.00263	CbGeAlD
Progesterone—Erythema multiforme—Methotrexate—muscle cancer	6.65e-05	0.00133	CcSEcCtD
Progesterone—Neuropathy peripheral—Doxorubicin—muscle cancer	6.65e-05	0.00133	CcSEcCtD
Progesterone—Urticaria—Etoposide—muscle cancer	6.62e-05	0.00133	CcSEcCtD
Progesterone—Jaundice—Doxorubicin—muscle cancer	6.61e-05	0.00133	CcSEcCtD
Progesterone—Body temperature increased—Etoposide—muscle cancer	6.59e-05	0.00132	CcSEcCtD
Progesterone—Abdominal pain—Etoposide—muscle cancer	6.59e-05	0.00132	CcSEcCtD
Progesterone—Urinary tract infection—Doxorubicin—muscle cancer	6.59e-05	0.00132	CcSEcCtD
Progesterone—Conjunctivitis—Doxorubicin—muscle cancer	6.59e-05	0.00132	CcSEcCtD
Progesterone—Eye disorder—Methotrexate—muscle cancer	6.57e-05	0.00132	CcSEcCtD
Progesterone—Tinnitus—Methotrexate—muscle cancer	6.55e-05	0.00132	CcSEcCtD
Progesterone—Vomiting—Vincristine—muscle cancer	6.54e-05	0.00131	CcSEcCtD
Progesterone—Cardiac disorder—Methotrexate—muscle cancer	6.52e-05	0.00131	CcSEcCtD
Progesterone—Rash—Vincristine—muscle cancer	6.49e-05	0.0013	CcSEcCtD
Progesterone—ABCB1—testis—muscle cancer	6.48e-05	0.00254	CbGeAlD
Progesterone—Dermatitis—Vincristine—muscle cancer	6.48e-05	0.0013	CcSEcCtD
Progesterone—Headache—Vincristine—muscle cancer	6.45e-05	0.00129	CcSEcCtD
Progesterone—Hepatobiliary disease—Doxorubicin—muscle cancer	6.41e-05	0.00129	CcSEcCtD
Progesterone—Angiopathy—Methotrexate—muscle cancer	6.38e-05	0.00128	CcSEcCtD
Progesterone—Sinusitis—Doxorubicin—muscle cancer	6.36e-05	0.00128	CcSEcCtD
Progesterone—Immune system disorder—Methotrexate—muscle cancer	6.35e-05	0.00127	CcSEcCtD
Progesterone—Mediastinal disorder—Methotrexate—muscle cancer	6.34e-05	0.00127	CcSEcCtD
Progesterone—Alopecia—Methotrexate—muscle cancer	6.21e-05	0.00125	CcSEcCtD
Progesterone—Mental disorder—Methotrexate—muscle cancer	6.16e-05	0.00124	CcSEcCtD
Progesterone—Hypersensitivity—Etoposide—muscle cancer	6.14e-05	0.00123	CcSEcCtD
Progesterone—Malnutrition—Methotrexate—muscle cancer	6.12e-05	0.00123	CcSEcCtD
Progesterone—Erythema—Methotrexate—muscle cancer	6.12e-05	0.00123	CcSEcCtD
Progesterone—Haemoglobin—Doxorubicin—muscle cancer	6.12e-05	0.00123	CcSEcCtD
Progesterone—Nausea—Vincristine—muscle cancer	6.11e-05	0.00123	CcSEcCtD
Progesterone—Rhinitis—Doxorubicin—muscle cancer	6.1e-05	0.00122	CcSEcCtD
Progesterone—Haemorrhage—Doxorubicin—muscle cancer	6.09e-05	0.00122	CcSEcCtD
Progesterone—Hepatitis—Doxorubicin—muscle cancer	6.09e-05	0.00122	CcSEcCtD
Progesterone—Pharyngitis—Doxorubicin—muscle cancer	6.04e-05	0.00121	CcSEcCtD
Progesterone—Urinary tract disorder—Doxorubicin—muscle cancer	6.01e-05	0.00121	CcSEcCtD
Progesterone—Oedema peripheral—Doxorubicin—muscle cancer	6e-05	0.0012	CcSEcCtD
Progesterone—Asthenia—Etoposide—muscle cancer	5.98e-05	0.0012	CcSEcCtD
Progesterone—Connective tissue disorder—Doxorubicin—muscle cancer	5.98e-05	0.0012	CcSEcCtD
Progesterone—Urethral disorder—Doxorubicin—muscle cancer	5.97e-05	0.0012	CcSEcCtD
Progesterone—Back pain—Methotrexate—muscle cancer	5.92e-05	0.00119	CcSEcCtD
Progesterone—Pruritus—Etoposide—muscle cancer	5.9e-05	0.00118	CcSEcCtD
Progesterone—Visual impairment—Doxorubicin—muscle cancer	5.87e-05	0.00118	CcSEcCtD
Progesterone—Vision blurred—Methotrexate—muscle cancer	5.77e-05	0.00116	CcSEcCtD
Progesterone—Erythema multiforme—Doxorubicin—muscle cancer	5.76e-05	0.00115	CcSEcCtD
Progesterone—Diarrhoea—Etoposide—muscle cancer	5.7e-05	0.00114	CcSEcCtD
Progesterone—Eye disorder—Doxorubicin—muscle cancer	5.69e-05	0.00114	CcSEcCtD
Progesterone—Ill-defined disorder—Methotrexate—muscle cancer	5.68e-05	0.00114	CcSEcCtD
Progesterone—Tinnitus—Doxorubicin—muscle cancer	5.68e-05	0.00114	CcSEcCtD
Progesterone—Anaemia—Methotrexate—muscle cancer	5.66e-05	0.00114	CcSEcCtD
Progesterone—Cardiac disorder—Doxorubicin—muscle cancer	5.65e-05	0.00113	CcSEcCtD
Progesterone—Angiopathy—Doxorubicin—muscle cancer	5.52e-05	0.00111	CcSEcCtD
Progesterone—Malaise—Methotrexate—muscle cancer	5.52e-05	0.00111	CcSEcCtD
Progesterone—Dizziness—Etoposide—muscle cancer	5.51e-05	0.00111	CcSEcCtD
Progesterone—Immune system disorder—Doxorubicin—muscle cancer	5.5e-05	0.0011	CcSEcCtD
Progesterone—Vertigo—Methotrexate—muscle cancer	5.5e-05	0.0011	CcSEcCtD
Progesterone—Mediastinal disorder—Doxorubicin—muscle cancer	5.49e-05	0.0011	CcSEcCtD
Progesterone—Alopecia—Doxorubicin—muscle cancer	5.38e-05	0.00108	CcSEcCtD
Progesterone—Cough—Methotrexate—muscle cancer	5.34e-05	0.00107	CcSEcCtD
Progesterone—Mental disorder—Doxorubicin—muscle cancer	5.33e-05	0.00107	CcSEcCtD
Progesterone—Convulsion—Methotrexate—muscle cancer	5.3e-05	0.00106	CcSEcCtD
Progesterone—Vomiting—Etoposide—muscle cancer	5.3e-05	0.00106	CcSEcCtD
Progesterone—Malnutrition—Doxorubicin—muscle cancer	5.3e-05	0.00106	CcSEcCtD
Progesterone—Erythema—Doxorubicin—muscle cancer	5.3e-05	0.00106	CcSEcCtD
Progesterone—Rash—Etoposide—muscle cancer	5.26e-05	0.00105	CcSEcCtD
Progesterone—Dermatitis—Etoposide—muscle cancer	5.25e-05	0.00105	CcSEcCtD
Progesterone—Headache—Etoposide—muscle cancer	5.22e-05	0.00105	CcSEcCtD
Progesterone—Flatulence—Doxorubicin—muscle cancer	5.22e-05	0.00105	CcSEcCtD
Progesterone—Myalgia—Methotrexate—muscle cancer	5.21e-05	0.00105	CcSEcCtD
Progesterone—Chest pain—Methotrexate—muscle cancer	5.21e-05	0.00105	CcSEcCtD
Progesterone—Arthralgia—Methotrexate—muscle cancer	5.21e-05	0.00105	CcSEcCtD
Progesterone—Tension—Doxorubicin—muscle cancer	5.2e-05	0.00104	CcSEcCtD
Progesterone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	5.17e-05	0.00104	CcSEcCtD
Progesterone—Discomfort—Methotrexate—muscle cancer	5.15e-05	0.00103	CcSEcCtD
Progesterone—Nervousness—Doxorubicin—muscle cancer	5.15e-05	0.00103	CcSEcCtD
Progesterone—Back pain—Doxorubicin—muscle cancer	5.13e-05	0.00103	CcSEcCtD
Progesterone—Muscle spasms—Doxorubicin—muscle cancer	5.09e-05	0.00102	CcSEcCtD
Progesterone—Confusional state—Methotrexate—muscle cancer	5.04e-05	0.00101	CcSEcCtD
Progesterone—Anaphylactic shock—Methotrexate—muscle cancer	4.99e-05	0.001	CcSEcCtD
Progesterone—Vision blurred—Doxorubicin—muscle cancer	4.99e-05	0.001	CcSEcCtD
Progesterone—Infection—Methotrexate—muscle cancer	4.96e-05	0.000996	CcSEcCtD
Progesterone—Nausea—Etoposide—muscle cancer	4.95e-05	0.000994	CcSEcCtD
Progesterone—Ill-defined disorder—Doxorubicin—muscle cancer	4.92e-05	0.000987	CcSEcCtD
Progesterone—Nervous system disorder—Methotrexate—muscle cancer	4.9e-05	0.000983	CcSEcCtD
Progesterone—Anaemia—Doxorubicin—muscle cancer	4.9e-05	0.000983	CcSEcCtD
Progesterone—Skin disorder—Methotrexate—muscle cancer	4.85e-05	0.000973	CcSEcCtD
Progesterone—Hyperhidrosis—Methotrexate—muscle cancer	4.83e-05	0.000969	CcSEcCtD
Progesterone—Malaise—Doxorubicin—muscle cancer	4.78e-05	0.000959	CcSEcCtD
Progesterone—Vertigo—Doxorubicin—muscle cancer	4.76e-05	0.000955	CcSEcCtD
Progesterone—Anorexia—Methotrexate—muscle cancer	4.76e-05	0.000955	CcSEcCtD
Progesterone—Syncope—Doxorubicin—muscle cancer	4.75e-05	0.000954	CcSEcCtD
Progesterone—Palpitations—Doxorubicin—muscle cancer	4.68e-05	0.00094	CcSEcCtD
Progesterone—Hypotension—Methotrexate—muscle cancer	4.67e-05	0.000937	CcSEcCtD
Progesterone—Loss of consciousness—Doxorubicin—muscle cancer	4.66e-05	0.000935	CcSEcCtD
Progesterone—Cough—Doxorubicin—muscle cancer	4.62e-05	0.000928	CcSEcCtD
Progesterone—Convulsion—Doxorubicin—muscle cancer	4.59e-05	0.000921	CcSEcCtD
Progesterone—Hypertension—Doxorubicin—muscle cancer	4.57e-05	0.000918	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Methotrexate—muscle cancer	4.55e-05	0.000913	CcSEcCtD
Progesterone—Insomnia—Methotrexate—muscle cancer	4.52e-05	0.000906	CcSEcCtD
Progesterone—Arthralgia—Doxorubicin—muscle cancer	4.51e-05	0.000905	CcSEcCtD
Progesterone—Chest pain—Doxorubicin—muscle cancer	4.51e-05	0.000905	CcSEcCtD
Progesterone—Myalgia—Doxorubicin—muscle cancer	4.51e-05	0.000905	CcSEcCtD
Progesterone—Anxiety—Doxorubicin—muscle cancer	4.5e-05	0.000902	CcSEcCtD
Progesterone—Paraesthesia—Methotrexate—muscle cancer	4.48e-05	0.0009	CcSEcCtD
Progesterone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	4.48e-05	0.000899	CcSEcCtD
Progesterone—Discomfort—Doxorubicin—muscle cancer	4.46e-05	0.000894	CcSEcCtD
Progesterone—Dyspnoea—Methotrexate—muscle cancer	4.45e-05	0.000894	CcSEcCtD
Progesterone—Somnolence—Methotrexate—muscle cancer	4.44e-05	0.000891	CcSEcCtD
Progesterone—Dry mouth—Doxorubicin—muscle cancer	4.41e-05	0.000885	CcSEcCtD
Progesterone—Dyspepsia—Methotrexate—muscle cancer	4.4e-05	0.000882	CcSEcCtD
Progesterone—Confusional state—Doxorubicin—muscle cancer	4.36e-05	0.000875	CcSEcCtD
Progesterone—Decreased appetite—Methotrexate—muscle cancer	4.34e-05	0.000871	CcSEcCtD
Progesterone—Anaphylactic shock—Doxorubicin—muscle cancer	4.32e-05	0.000868	CcSEcCtD
Progesterone—Oedema—Doxorubicin—muscle cancer	4.32e-05	0.000868	CcSEcCtD
Progesterone—Gastrointestinal disorder—Methotrexate—muscle cancer	4.31e-05	0.000865	CcSEcCtD
Progesterone—Fatigue—Methotrexate—muscle cancer	4.31e-05	0.000864	CcSEcCtD
Progesterone—Infection—Doxorubicin—muscle cancer	4.3e-05	0.000862	CcSEcCtD
Progesterone—Pain—Methotrexate—muscle cancer	4.27e-05	0.000857	CcSEcCtD
Progesterone—Shock—Doxorubicin—muscle cancer	4.25e-05	0.000854	CcSEcCtD
Progesterone—Nervous system disorder—Doxorubicin—muscle cancer	4.24e-05	0.000851	CcSEcCtD
Progesterone—Tachycardia—Doxorubicin—muscle cancer	4.22e-05	0.000847	CcSEcCtD
Progesterone—Skin disorder—Doxorubicin—muscle cancer	4.2e-05	0.000843	CcSEcCtD
Progesterone—Hyperhidrosis—Doxorubicin—muscle cancer	4.18e-05	0.000839	CcSEcCtD
Progesterone—Anorexia—Doxorubicin—muscle cancer	4.12e-05	0.000827	CcSEcCtD
Progesterone—Feeling abnormal—Methotrexate—muscle cancer	4.12e-05	0.000826	CcSEcCtD
Progesterone—Gastrointestinal pain—Methotrexate—muscle cancer	4.08e-05	0.00082	CcSEcCtD
Progesterone—Hypotension—Doxorubicin—muscle cancer	4.04e-05	0.000811	CcSEcCtD
Progesterone—Urticaria—Methotrexate—muscle cancer	3.97e-05	0.000796	CcSEcCtD
Progesterone—Abdominal pain—Methotrexate—muscle cancer	3.95e-05	0.000792	CcSEcCtD
Progesterone—Body temperature increased—Methotrexate—muscle cancer	3.95e-05	0.000792	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Doxorubicin—muscle cancer	3.94e-05	0.000791	CcSEcCtD
Progesterone—Insomnia—Doxorubicin—muscle cancer	3.91e-05	0.000785	CcSEcCtD
Progesterone—Paraesthesia—Doxorubicin—muscle cancer	3.88e-05	0.000779	CcSEcCtD
Progesterone—Dyspnoea—Doxorubicin—muscle cancer	3.86e-05	0.000774	CcSEcCtD
Progesterone—Somnolence—Doxorubicin—muscle cancer	3.84e-05	0.000772	CcSEcCtD
Progesterone—Dyspepsia—Doxorubicin—muscle cancer	3.81e-05	0.000764	CcSEcCtD
Progesterone—Decreased appetite—Doxorubicin—muscle cancer	3.76e-05	0.000754	CcSEcCtD
Progesterone—Gastrointestinal disorder—Doxorubicin—muscle cancer	3.73e-05	0.000749	CcSEcCtD
Progesterone—Fatigue—Doxorubicin—muscle cancer	3.73e-05	0.000748	CcSEcCtD
Progesterone—Constipation—Doxorubicin—muscle cancer	3.7e-05	0.000742	CcSEcCtD
Progesterone—Pain—Doxorubicin—muscle cancer	3.7e-05	0.000742	CcSEcCtD
Progesterone—Hypersensitivity—Methotrexate—muscle cancer	3.68e-05	0.000738	CcSEcCtD
Progesterone—Asthenia—Methotrexate—muscle cancer	3.58e-05	0.000719	CcSEcCtD
Progesterone—Feeling abnormal—Doxorubicin—muscle cancer	3.56e-05	0.000715	CcSEcCtD
Progesterone—Gastrointestinal pain—Doxorubicin—muscle cancer	3.54e-05	0.00071	CcSEcCtD
Progesterone—Pruritus—Methotrexate—muscle cancer	3.53e-05	0.000709	CcSEcCtD
Progesterone—Urticaria—Doxorubicin—muscle cancer	3.44e-05	0.000689	CcSEcCtD
Progesterone—Abdominal pain—Doxorubicin—muscle cancer	3.42e-05	0.000686	CcSEcCtD
Progesterone—Body temperature increased—Doxorubicin—muscle cancer	3.42e-05	0.000686	CcSEcCtD
Progesterone—Diarrhoea—Methotrexate—muscle cancer	3.42e-05	0.000686	CcSEcCtD
Progesterone—Dizziness—Methotrexate—muscle cancer	3.3e-05	0.000663	CcSEcCtD
Progesterone—Hypersensitivity—Doxorubicin—muscle cancer	3.19e-05	0.000639	CcSEcCtD
Progesterone—Vomiting—Methotrexate—muscle cancer	3.18e-05	0.000637	CcSEcCtD
Progesterone—Rash—Methotrexate—muscle cancer	3.15e-05	0.000632	CcSEcCtD
Progesterone—Dermatitis—Methotrexate—muscle cancer	3.15e-05	0.000631	CcSEcCtD
Progesterone—Headache—Methotrexate—muscle cancer	3.13e-05	0.000628	CcSEcCtD
Progesterone—Asthenia—Doxorubicin—muscle cancer	3.1e-05	0.000623	CcSEcCtD
Progesterone—Pruritus—Doxorubicin—muscle cancer	3.06e-05	0.000614	CcSEcCtD
Progesterone—Nausea—Methotrexate—muscle cancer	2.97e-05	0.000595	CcSEcCtD
Progesterone—Diarrhoea—Doxorubicin—muscle cancer	2.96e-05	0.000594	CcSEcCtD
Progesterone—Dizziness—Doxorubicin—muscle cancer	2.86e-05	0.000574	CcSEcCtD
Progesterone—Vomiting—Doxorubicin—muscle cancer	2.75e-05	0.000552	CcSEcCtD
Progesterone—Rash—Doxorubicin—muscle cancer	2.73e-05	0.000547	CcSEcCtD
Progesterone—Dermatitis—Doxorubicin—muscle cancer	2.72e-05	0.000547	CcSEcCtD
Progesterone—Headache—Doxorubicin—muscle cancer	2.71e-05	0.000544	CcSEcCtD
Progesterone—Nausea—Doxorubicin—muscle cancer	2.57e-05	0.000515	CcSEcCtD
Progesterone—PGR—Signaling by ERBB4—FOXO4—muscle cancer	7.91e-06	0.00853	CbGpPWpGaD
Progesterone—NR3C1—Regulation of Androgen receptor activity—FOXO1—muscle cancer	7.85e-06	0.00846	CbGpPWpGaD
Progesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—FOXO4—muscle cancer	7.68e-06	0.00828	CbGpPWpGaD
Progesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOXO4—muscle cancer	7.57e-06	0.00816	CbGpPWpGaD
Progesterone—AR—Regulation of nuclear SMAD2/3 signaling—FOXO1—muscle cancer	7.37e-06	0.00794	CbGpPWpGaD
Progesterone—NR3C2—Generic Transcription Pathway—MED12—muscle cancer	7.23e-06	0.0078	CbGpPWpGaD
Progesterone—CYP2C19—Melatonin metabolism and effects—FOXO1—muscle cancer	7e-06	0.00754	CbGpPWpGaD
Progesterone—AR—Integrated Pancreatic Cancer Pathway—WT1—muscle cancer	6.87e-06	0.0074	CbGpPWpGaD
Progesterone—AR—Androgen receptor signaling pathway—FOXO1—muscle cancer	6.83e-06	0.00736	CbGpPWpGaD
Progesterone—CYP2C19—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	6.47e-06	0.00697	CbGpPWpGaD
Progesterone—CYP2D6—Melatonin metabolism and effects—FOXO1—muscle cancer	6.43e-06	0.00694	CbGpPWpGaD
Progesterone—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—muscle cancer	6.42e-06	0.00692	CbGpPWpGaD
Progesterone—ABCB1—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	6.31e-06	0.0068	CbGpPWpGaD
Progesterone—AR—Regulation of Androgen receptor activity—MDM2—muscle cancer	6.21e-06	0.00669	CbGpPWpGaD
Progesterone—ESR1—Leptin signaling pathway—FOXO1—muscle cancer	6.03e-06	0.00651	CbGpPWpGaD
Progesterone—ESR1—FOXM1 transcription factor network—CDKN2A—muscle cancer	5.94e-06	0.0064	CbGpPWpGaD
Progesterone—CYP2C9—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	5.9e-06	0.00636	CbGpPWpGaD
Progesterone—PGR—Signaling by ERBB4—FOXO1—muscle cancer	5.84e-06	0.0063	CbGpPWpGaD
Progesterone—NR3C1—Adipogenesis—HMGA1—muscle cancer	5.78e-06	0.00623	CbGpPWpGaD
Progesterone—CYP1B1—Tryptophan metabolism—MDM2—muscle cancer	5.76e-06	0.00621	CbGpPWpGaD
Progesterone—AR—Coregulation of Androgen receptor activity—CDKN2A—muscle cancer	5.72e-06	0.00616	CbGpPWpGaD
Progesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—FOXO1—muscle cancer	5.67e-06	0.00612	CbGpPWpGaD
Progesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOXO1—muscle cancer	5.59e-06	0.00602	CbGpPWpGaD
Progesterone—CYP1B1—Aryl Hydrocarbon Receptor—PTGS2—muscle cancer	5.55e-06	0.00599	CbGpPWpGaD
Progesterone—SLC10A1—Metabolism of lipids and lipoproteins—MED12—muscle cancer	5.46e-06	0.00588	CbGpPWpGaD
Progesterone—CYP1A2—Melatonin metabolism and effects—FOXO1—muscle cancer	5.45e-06	0.00588	CbGpPWpGaD
Progesterone—ABCC1—Arachidonic acid metabolism—PTGS2—muscle cancer	5.37e-06	0.00579	CbGpPWpGaD
Progesterone—CYP1A1—PPARA activates gene expression—MED12—muscle cancer	5.36e-06	0.00578	CbGpPWpGaD
Progesterone—ESR1—Integrated Pancreatic Cancer Pathway—WT1—muscle cancer	5.29e-06	0.0057	CbGpPWpGaD
Progesterone—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—MED12—muscle cancer	5.25e-06	0.00566	CbGpPWpGaD
Progesterone—CYP1B1—Arachidonic acid metabolism—PTGS2—muscle cancer	5.19e-06	0.0056	CbGpPWpGaD
Progesterone—ESR1—Aryl Hydrocarbon Receptor—PTGS2—muscle cancer	5.16e-06	0.00556	CbGpPWpGaD
Progesterone—AR—Integrated Pancreatic Cancer Pathway—BUB1B—muscle cancer	5.02e-06	0.00541	CbGpPWpGaD
Progesterone—NR3C1—Regulation of Androgen receptor activity—MDM2—muscle cancer	4.71e-06	0.00508	CbGpPWpGaD
Progesterone—ESR1—Signaling by ERBB4—FOXO4—muscle cancer	4.64e-06	0.00501	CbGpPWpGaD
Progesterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—muscle cancer	4.6e-06	0.00496	CbGpPWpGaD
Progesterone—AR—Integrated Breast Cancer Pathway—FOXO1—muscle cancer	4.48e-06	0.00482	CbGpPWpGaD
Progesterone—PGR—Signaling by ERBB4—KIT—muscle cancer	4.45e-06	0.0048	CbGpPWpGaD
Progesterone—PGR—Generic Transcription Pathway—MED12—muscle cancer	4.41e-06	0.00475	CbGpPWpGaD
Progesterone—CYP1B1—Aryl Hydrocarbon Receptor—VEGFA—muscle cancer	4.37e-06	0.00471	CbGpPWpGaD
Progesterone—SLC10A1—Metabolism—FH—muscle cancer	4.3e-06	0.00464	CbGpPWpGaD
Progesterone—OPRK1—G alpha (i) signalling events—CNR1—muscle cancer	4.29e-06	0.00463	CbGpPWpGaD
Progesterone—AR—Androgen receptor signaling pathway—MDM2—muscle cancer	4.1e-06	0.00442	CbGpPWpGaD
Progesterone—ESR1—Aryl Hydrocarbon Receptor—VEGFA—muscle cancer	4.07e-06	0.00438	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism of lipids and lipoproteins—MED12—muscle cancer	4.01e-06	0.00432	CbGpPWpGaD
Progesterone—OPRK1—GPCRs, Class A Rhodopsin-like—CNR1—muscle cancer	3.98e-06	0.00429	CbGpPWpGaD
Progesterone—ESR1—AP-1 transcription factor network—CDKN2A—muscle cancer	3.95e-06	0.00425	CbGpPWpGaD
Progesterone—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	3.89e-06	0.00419	CbGpPWpGaD
Progesterone—NR3C1—AP-1 transcription factor network—CDKN2A—muscle cancer	3.89e-06	0.00419	CbGpPWpGaD
Progesterone—ESR1—Integrated Pancreatic Cancer Pathway—BUB1B—muscle cancer	3.87e-06	0.00417	CbGpPWpGaD
Progesterone—NR3C1—Adipogenesis—FOXO1—muscle cancer	3.83e-06	0.00413	CbGpPWpGaD
Progesterone—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—muscle cancer	3.82e-06	0.00412	CbGpPWpGaD
Progesterone—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—MED12—muscle cancer	3.62e-06	0.0039	CbGpPWpGaD
Progesterone—CYP2A6—Fluoropyrimidine Activity—TP53—muscle cancer	3.56e-06	0.00384	CbGpPWpGaD
Progesterone—CYP1A1—Tryptophan metabolism—MDM2—muscle cancer	3.55e-06	0.00382	CbGpPWpGaD
Progesterone—PGR—Signaling by ERBB4—MDM2—muscle cancer	3.51e-06	0.00378	CbGpPWpGaD
Progesterone—NR3C2—Gene Expression—MED12—muscle cancer	3.48e-06	0.00375	CbGpPWpGaD
Progesterone—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—muscle cancer	3.45e-06	0.00372	CbGpPWpGaD
Progesterone—ESR1—Integrated Breast Cancer Pathway—FOXO1—muscle cancer	3.45e-06	0.00372	CbGpPWpGaD
Progesterone—ESR1—Signaling by ERBB4—FOXO1—muscle cancer	3.43e-06	0.0037	CbGpPWpGaD
Progesterone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—muscle cancer	3.42e-06	0.00369	CbGpPWpGaD
Progesterone—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—muscle cancer	3.42e-06	0.00369	CbGpPWpGaD
Progesterone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CNR1—muscle cancer	3.41e-06	0.00368	CbGpPWpGaD
Progesterone—AR—Generic Transcription Pathway—MED12—muscle cancer	3.36e-06	0.00362	CbGpPWpGaD
Progesterone—NR3C1—Glucocorticoid receptor regulatory network—MDM2—muscle cancer	3.32e-06	0.00358	CbGpPWpGaD
Progesterone—ESR1—LKB1 signaling events—TP53—muscle cancer	3.24e-06	0.0035	CbGpPWpGaD
Progesterone—ABCB11—Metabolism of lipids and lipoproteins—MED12—muscle cancer	3.22e-06	0.00347	CbGpPWpGaD
Progesterone—CYP1A1—Arachidonic acid metabolism—PTGS2—muscle cancer	3.2e-06	0.00345	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—FH—muscle cancer	3.16e-06	0.0034	CbGpPWpGaD
Progesterone—OPRK1—GPCR ligand binding—PTCH1—muscle cancer	3.08e-06	0.00332	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—KIDINS220—muscle cancer	3.03e-06	0.00326	CbGpPWpGaD
Progesterone—CYP2C8—Arachidonic acid metabolism—PTGS2—muscle cancer	2.93e-06	0.00316	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—muscle cancer	2.8e-06	0.00302	CbGpPWpGaD
Progesterone—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—muscle cancer	2.69e-06	0.0029	CbGpPWpGaD
Progesterone—AR—Integrated Breast Cancer Pathway—MDM2—muscle cancer	2.69e-06	0.0029	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—FH—muscle cancer	2.65e-06	0.00285	CbGpPWpGaD
Progesterone—CYP2C19—Arachidonic acid metabolism—PTGS2—muscle cancer	2.62e-06	0.00282	CbGpPWpGaD
Progesterone—ESR1—Signaling by ERBB4—KIT—muscle cancer	2.61e-06	0.00282	CbGpPWpGaD
Progesterone—OPRK1—GPCR ligand binding—CNR1—muscle cancer	2.6e-06	0.0028	CbGpPWpGaD
Progesterone—ESR1—Generic Transcription Pathway—MED12—muscle cancer	2.59e-06	0.00279	CbGpPWpGaD
Progesterone—NR3C1—Generic Transcription Pathway—MED12—muscle cancer	2.55e-06	0.00274	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—FH—muscle cancer	2.54e-06	0.00273	CbGpPWpGaD
Progesterone—SLC10A1—Metabolism—MED12—muscle cancer	2.43e-06	0.00262	CbGpPWpGaD
Progesterone—ABCC1—Metabolism of lipids and lipoproteins—MED12—muscle cancer	2.42e-06	0.00261	CbGpPWpGaD
Progesterone—CYP2C9—Arachidonic acid metabolism—PTGS2—muscle cancer	2.39e-06	0.00257	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—KIDINS220—muscle cancer	2.37e-06	0.00256	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism of lipids and lipoproteins—MED12—muscle cancer	2.34e-06	0.00252	CbGpPWpGaD
Progesterone—CYP1A2—Tryptophan metabolism—MDM2—muscle cancer	2.26e-06	0.00244	CbGpPWpGaD
Progesterone—AR—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	2.23e-06	0.0024	CbGpPWpGaD
Progesterone—SLC10A1—Metabolism—ENO2—muscle cancer	2.22e-06	0.00239	CbGpPWpGaD
Progesterone—ESR1—AP-1 transcription factor network—TP53—muscle cancer	2.2e-06	0.00237	CbGpPWpGaD
Progesterone—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—muscle cancer	2.18e-06	0.00235	CbGpPWpGaD
Progesterone—NR3C1—AP-1 transcription factor network—TP53—muscle cancer	2.16e-06	0.00233	CbGpPWpGaD
Progesterone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	2.15e-06	0.00231	CbGpPWpGaD
Progesterone—PGR—Gene Expression—MED12—muscle cancer	2.12e-06	0.00229	CbGpPWpGaD
Progesterone—ESR1—Integrated Breast Cancer Pathway—MDM2—muscle cancer	2.07e-06	0.00223	CbGpPWpGaD
Progesterone—ESR1—Signaling by ERBB4—MDM2—muscle cancer	2.06e-06	0.00222	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—muscle cancer	2.05e-06	0.00221	CbGpPWpGaD
Progesterone—CYP1A2—Arachidonic acid metabolism—PTGS2—muscle cancer	2.04e-06	0.0022	CbGpPWpGaD
Progesterone—AR—Integrated Breast Cancer Pathway—VEGFA—muscle cancer	2.04e-06	0.0022	CbGpPWpGaD
Progesterone—AR—SIDS Susceptibility Pathways—VEGFA—muscle cancer	1.99e-06	0.00214	CbGpPWpGaD
Progesterone—NR3C1—Glucocorticoid receptor regulatory network—TP53—muscle cancer	1.91e-06	0.00205	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—FH—muscle cancer	1.91e-06	0.00205	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—FH—muscle cancer	1.84e-06	0.00199	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—MED12—muscle cancer	1.78e-06	0.00192	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—KIDINS220—muscle cancer	1.78e-06	0.00192	CbGpPWpGaD
Progesterone—CYP3A4—Tryptophan metabolism—MDM2—muscle cancer	1.75e-06	0.00188	CbGpPWpGaD
Progesterone—SLC10A1—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	1.73e-06	0.00187	CbGpPWpGaD
Progesterone—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—muscle cancer	1.72e-06	0.00185	CbGpPWpGaD
Progesterone—ESR1—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	1.71e-06	0.00185	CbGpPWpGaD
Progesterone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	1.69e-06	0.00182	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—FH—muscle cancer	1.66e-06	0.00179	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—FH—muscle cancer	1.66e-06	0.00179	CbGpPWpGaD
Progesterone—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	1.65e-06	0.00178	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—ENO2—muscle cancer	1.63e-06	0.00175	CbGpPWpGaD
Progesterone—AR—Gene Expression—MED12—muscle cancer	1.62e-06	0.00174	CbGpPWpGaD
Progesterone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—muscle cancer	1.61e-06	0.00174	CbGpPWpGaD
Progesterone—SLC22A2—Transmission across Chemical Synapses—MDM2—muscle cancer	1.6e-06	0.00173	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—PTCH1—muscle cancer	1.58e-06	0.0017	CbGpPWpGaD
Progesterone—ESR1—Integrated Breast Cancer Pathway—VEGFA—muscle cancer	1.57e-06	0.00169	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—FH—muscle cancer	1.55e-06	0.00167	CbGpPWpGaD
Progesterone—AR—Integrated Breast Cancer Pathway—TP53—muscle cancer	1.54e-06	0.00166	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—FH—muscle cancer	1.52e-06	0.00164	CbGpPWpGaD
Progesterone—NR3C1—SIDS Susceptibility Pathways—VEGFA—muscle cancer	1.51e-06	0.00163	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—MED12—muscle cancer	1.49e-06	0.00161	CbGpPWpGaD
Progesterone—SLC22A1—Transmission across Chemical Synapses—MDM2—muscle cancer	1.49e-06	0.00161	CbGpPWpGaD
Progesterone—OPRK1—GPCR downstream signaling—CNR1—muscle cancer	1.47e-06	0.00158	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism of lipids and lipoproteins—MED12—muscle cancer	1.44e-06	0.00155	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—MED12—muscle cancer	1.43e-06	0.00154	CbGpPWpGaD
Progesterone—ABCB1—Allograft Rejection—VEGFA—muscle cancer	1.4e-06	0.0015	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—ENO2—muscle cancer	1.36e-06	0.00147	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—CNR1—muscle cancer	1.33e-06	0.00144	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism of lipids and lipoproteins—MED12—muscle cancer	1.32e-06	0.00142	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—ENO2—muscle cancer	1.31e-06	0.00141	CbGpPWpGaD
Progesterone—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	1.3e-06	0.0014	CbGpPWpGaD
Progesterone—AR—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	1.28e-06	0.00138	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	1.27e-06	0.00137	CbGpPWpGaD
Progesterone—ESR1—Gene Expression—MED12—muscle cancer	1.24e-06	0.00134	CbGpPWpGaD
Progesterone—SLC22A2—Neuronal System—MDM2—muscle cancer	1.23e-06	0.00132	CbGpPWpGaD
Progesterone—NR3C1—Gene Expression—MED12—muscle cancer	1.23e-06	0.00132	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—FH—muscle cancer	1.2e-06	0.00129	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—PTCH1—muscle cancer	1.19e-06	0.00128	CbGpPWpGaD
Progesterone—ESR1—Integrated Breast Cancer Pathway—TP53—muscle cancer	1.19e-06	0.00128	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism of lipids and lipoproteins—MED12—muscle cancer	1.18e-06	0.00127	CbGpPWpGaD
Progesterone—ABCC1—Disease—ENO2—muscle cancer	1.17e-06	0.00126	CbGpPWpGaD
Progesterone—SLC22A1—Neuronal System—MDM2—muscle cancer	1.14e-06	0.00123	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—FH—muscle cancer	1.13e-06	0.00122	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—MED12—muscle cancer	1.08e-06	0.00116	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—MED12—muscle cancer	1.07e-06	0.00116	CbGpPWpGaD
Progesterone—ABCC1—Disease—HMGA1—muscle cancer	1.07e-06	0.00115	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—MED12—muscle cancer	1.04e-06	0.00112	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—FH—muscle cancer	1.04e-06	0.00112	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—FOXO4—muscle cancer	1.02e-06	0.0011	CbGpPWpGaD
Progesterone—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	1.02e-06	0.0011	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—CNR1—muscle cancer	1.01e-06	0.00108	CbGpPWpGaD
Progesterone—ESR1—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	9.84e-07	0.00106	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—ENO2—muscle cancer	9.81e-07	0.00106	CbGpPWpGaD
Progesterone—ABCC1—Disease—FOXO4—muscle cancer	9.55e-07	0.00103	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—ENO2—muscle cancer	9.49e-07	0.00102	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—MED12—muscle cancer	9.39e-07	0.00101	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—MED12—muscle cancer	9.37e-07	0.00101	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—PTCH1—muscle cancer	9.33e-07	0.00101	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—FH—muscle cancer	9.29e-07	0.001	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—MED12—muscle cancer	9.18e-07	0.00099	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	9.07e-07	0.000978	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—FH—muscle cancer	9.06e-07	0.000977	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	8.74e-07	0.000943	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—MED12—muscle cancer	8.74e-07	0.000942	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—MED12—muscle cancer	8.61e-07	0.000928	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—ENO2—muscle cancer	8.56e-07	0.000923	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—ENO2—muscle cancer	8.55e-07	0.000921	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—FH—muscle cancer	8.54e-07	0.000921	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—FH—muscle cancer	8.47e-07	0.000913	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—IGF2—muscle cancer	8.22e-07	0.000887	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—FOXO4—muscle cancer	8.03e-07	0.000865	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—ENO2—muscle cancer	7.97e-07	0.000859	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—CNR1—muscle cancer	7.88e-07	0.000849	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—ENO2—muscle cancer	7.85e-07	0.000846	CbGpPWpGaD
Progesterone—SLC10A1—Metabolism—PTGS2—muscle cancer	7.72e-07	0.000832	CbGpPWpGaD
Progesterone—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	7.67e-07	0.000827	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—FOXO1—muscle cancer	7.57e-07	0.000816	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	7.42e-07	0.0008	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—FH—muscle cancer	7.23e-07	0.00078	CbGpPWpGaD
Progesterone—ABCC1—Disease—FOXO1—muscle cancer	7.06e-07	0.000761	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—PTCH1—muscle cancer	6.99e-07	0.000754	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	6.89e-07	0.000742	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—MED12—muscle cancer	6.79e-07	0.000732	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—IGF2—muscle cancer	6.44e-07	0.000694	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—MED12—muscle cancer	6.41e-07	0.000691	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—ENO2—muscle cancer	6.19e-07	0.000667	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—FOXO4—muscle cancer	6.01e-07	0.000648	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—FOXO1—muscle cancer	5.93e-07	0.000639	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CNR1—muscle cancer	5.9e-07	0.000636	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—MED12—muscle cancer	5.88e-07	0.000634	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—ENO2—muscle cancer	5.85e-07	0.00063	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—KIT—muscle cancer	5.77e-07	0.000622	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—PTGS2—muscle cancer	5.67e-07	0.000611	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—FH—muscle cancer	5.58e-07	0.000602	CbGpPWpGaD
Progesterone—ABCC1—Disease—KIT—muscle cancer	5.38e-07	0.000579	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—ENO2—muscle cancer	5.36e-07	0.000578	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—MED12—muscle cancer	5.25e-07	0.000566	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	5.2e-07	0.000561	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—MED12—muscle cancer	5.12e-07	0.000552	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—IGF2—muscle cancer	4.83e-07	0.00052	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—MED12—muscle cancer	4.83e-07	0.00052	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—MED12—muscle cancer	4.78e-07	0.000516	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—ENO2—muscle cancer	4.78e-07	0.000516	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—PTGS2—muscle cancer	4.75e-07	0.000512	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—ENO2—muscle cancer	4.67e-07	0.000503	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	4.57e-07	0.000493	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—PTGS2—muscle cancer	4.55e-07	0.00049	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—MDM2—muscle cancer	4.54e-07	0.00049	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—KIT—muscle cancer	4.52e-07	0.000487	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—FOXO1—muscle cancer	4.44e-07	0.000479	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—ENO2—muscle cancer	4.4e-07	0.000474	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—ENO2—muscle cancer	4.36e-07	0.00047	CbGpPWpGaD
Progesterone—ABCC1—Disease—MDM2—muscle cancer	4.23e-07	0.000456	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	4.19e-07	0.000452	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—MED12—muscle cancer	4.09e-07	0.000441	CbGpPWpGaD
Progesterone—ABCC1—Disease—PTGS2—muscle cancer	4.08e-07	0.00044	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	3.74e-07	0.000403	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—ENO2—muscle cancer	3.73e-07	0.000402	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—MDM2—muscle cancer	3.56e-07	0.000383	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—VEGFA—muscle cancer	3.45e-07	0.000372	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—PTGS2—muscle cancer	3.42e-07	0.000368	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	3.41e-07	0.000368	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—KIT—muscle cancer	3.38e-07	0.000365	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—PTGS2—muscle cancer	3.31e-07	0.000356	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—MED12—muscle cancer	3.16e-07	0.00034	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—PTGS2—muscle cancer	2.98e-07	0.000321	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—PTGS2—muscle cancer	2.98e-07	0.000321	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	2.91e-07	0.000314	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—ENO2—muscle cancer	2.88e-07	0.00031	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—PTGS2—muscle cancer	2.77e-07	0.000299	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—PTGS2—muscle cancer	2.73e-07	0.000295	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—VEGFA—muscle cancer	2.7e-07	0.000291	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—MDM2—muscle cancer	2.67e-07	0.000287	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—TP53—muscle cancer	2.61e-07	0.000281	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PTGS2—muscle cancer	2.15e-07	0.000232	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—TP53—muscle cancer	2.04e-07	0.00022	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PTGS2—muscle cancer	2.04e-07	0.000219	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—VEGFA—muscle cancer	2.02e-07	0.000218	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PTGS2—muscle cancer	1.87e-07	0.000201	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PTGS2—muscle cancer	1.67e-07	0.00018	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PTGS2—muscle cancer	1.63e-07	0.000175	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PTGS2—muscle cancer	1.53e-07	0.000165	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—TP53—muscle cancer	1.53e-07	0.000165	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PTGS2—muscle cancer	1.52e-07	0.000164	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PTGS2—muscle cancer	1.3e-07	0.00014	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PTGS2—muscle cancer	1e-07	0.000108	CbGpPWpGaD
